arsenic trioxide has been researched along with Colorectal Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Guo, N; Li, D; Li, Y; Liu, D; Liu, M; Wang, C; Wang, G; Yu, K; Zheng, X | 1 |
| Alimoghaddam, K; Eyvani, H; Ghaffari, SH; Ghavamzadeh, A; Kabuli, M; Moghaddaskho, F; Momeny, M; Tavakkoly-Bazzaz, J; Zekri, A | 1 |
| Dong, D; Fu, S; Wang, G; Wang, X; Yang, B | 1 |
| Ardalan, B; Duncan, R; Fernandez, A; Ganjei-Azar, P; Gonzalez, M; Lee, K; Lima, M; Mezentsev, D; Podolsky, L; Ramos, Y; Reis, I; Subbarayan, PR | 1 |
| Ardalan, B; Lee, K; Subbarayan, PR | 1 |
| Ardalan, B; Francheschi, D; Livingstone, A; Oh, M; Podolsky, L; Subbarayan, PR | 1 |
| Ardalan, B; Lima, M; Subbarayan, PR | 1 |
2 trial(s) available for arsenic trioxide and Colorectal Neoplasms
| Article | Year |
|---|---|
A phase I study of 5-fluorouracil/leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Colorectal Neoplasms; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Oxides; Thymidylate Synthase | 2010 |
Arsenic trioxide/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: a clinical experience.
Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Colorectal Neoplasms; DNA Primers; Gene Expression Regulation; Humans; Middle Aged; Neoplasm Metastasis; Oxides; Thymidylate Synthase; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
5 other study(ies) available for arsenic trioxide and Colorectal Neoplasms
| Article | Year |
|---|---|
Release of volatile organic compounds (VOCs) from colorectal cancer cell line LS174T.
Topics: Animals; Arsenic Trioxide; Cell Line, Tumor; Colorectal Neoplasms; Female; Gas Chromatography-Mass Spectrometry; Humans; Mice, Inbred BALB C; Mice, Nude; Volatile Organic Compounds | 2019 |
Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Cycle Checkpoints; Cell Line, Tumor; Colon; Colorectal Neoplasms; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Oxides; Rectum; Retinoblastoma-Like Protein p107 | 2016 |
Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Nucleus; Cell Survival; Colorectal Neoplasms; Cytoplasmic Structures; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Formazans; Humans; Mice; Mice, Nude; Oxides; Polymerase Chain Reaction; Telomerase; Tetrazolium Salts; Xenograft Model Antitumor Assays | 2008 |
Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Blotting, Western; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Gene Expression; HT29 Cells; Humans; Oxides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymidylate Synthase; Tumor Suppressor Protein p53 | 2010 |
5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: a clinical experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Clinical Trials, Phase I as Topic; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Treatment Outcome | 2011 |